RC118

DB18428InvestigationalProtein Based Therapies

RC118 is an antibody-drug conjugate that consists of a recombinant humanized IgG1 anti-Claudin18.2 monoclonal antibody conjugated to MMAE.

Mechanism: Pharmacologically active on Tubulin and Claudin-18
Curator reviewed
Also known as: Recombinant humanized anti-MSLN monoclonal antibody- monomethyl auristatin E conjugate
Code names: RC-118

Resolves to

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with RC118, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.